NO20022245D0 - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer

Info

Publication number
NO20022245D0
NO20022245D0 NO20022245A NO20022245A NO20022245D0 NO 20022245 D0 NO20022245 D0 NO 20022245D0 NO 20022245 A NO20022245 A NO 20022245A NO 20022245 A NO20022245 A NO 20022245A NO 20022245 D0 NO20022245 D0 NO 20022245D0
Authority
NO
Norway
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Application number
NO20022245A
Other languages
Norwegian (no)
Other versions
NO20022245L (en
Inventor
Jerome Herbert Fleisch
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Douglas Wade Beight
Edward C R Smith
William Thomas Mcmillen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20022245D0 publication Critical patent/NO20022245D0/en
Publication of NO20022245L publication Critical patent/NO20022245L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20022245A 1999-11-11 2002-05-10 Oncolytic combinations for the treatment of cancer NO20022245L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (2)

Publication Number Publication Date
NO20022245D0 true NO20022245D0 (en) 2002-05-10
NO20022245L NO20022245L (en) 2002-07-09

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022245A NO20022245L (en) 1999-11-11 2002-05-10 Oncolytic combinations for the treatment of cancer

Country Status (22)

Country Link
EP (1) EP1231938A2 (en)
JP (1) JP2003513916A (en)
KR (1) KR20020069512A (en)
CN (1) CN1390139A (en)
AR (1) AR032432A1 (en)
AU (1) AU778829B2 (en)
BR (1) BR0015490A (en)
CA (1) CA2391416A1 (en)
CZ (1) CZ20021551A3 (en)
EA (1) EA200200545A1 (en)
HK (1) HK1050132A1 (en)
HU (1) HUP0204449A3 (en)
IL (1) IL148579A0 (en)
MX (1) MXPA02004733A (en)
NO (1) NO20022245L (en)
NZ (1) NZ517667A (en)
PE (1) PE20010701A1 (en)
PL (1) PL355172A1 (en)
SK (1) SK6492002A3 (en)
TR (1) TR200201245T2 (en)
WO (1) WO2001034137A2 (en)
ZA (1) ZA200202822B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Combination therapy for cancer
WO2001085166A1 (en) * 2000-05-09 2001-11-15 Creighton University Methods for inhibiting proliferation and inducing apoptosis in cancer cells
EP1311262A4 (en) 2000-07-28 2005-06-01 Cancer Rec Tech Ltd Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
EP1745003B1 (en) 2004-05-05 2010-10-27 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (en) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 Jixitabing hydrochloride solution type injection agent
ATE529404T1 (en) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc PHENOXYACETIC ACIDS AS PPAR-DELTA ACTIVATORS
NZ568488A (en) 2005-12-22 2011-07-29 High Point Pharmaceuticals Llc Phenoxy acetic acids as PPAR delta activators
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
EP2080751A4 (en) 2006-10-12 2011-06-22 Inst Med Molecular Design Inc Carboxylic acid derivative
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
JP2016503395A (en) 2012-10-31 2016-02-04 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Heterocyclic compounds as pest control agents
CN103319466B (en) * 2013-07-04 2016-03-16 郑州大学 Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
HUP0204449A2 (en) 2003-04-28
PE20010701A1 (en) 2001-07-07
SK6492002A3 (en) 2003-09-11
IL148579A0 (en) 2002-09-12
PL355172A1 (en) 2004-04-05
MXPA02004733A (en) 2002-08-30
AU1599001A (en) 2001-06-06
HK1050132A1 (en) 2003-06-13
JP2003513916A (en) 2003-04-15
CN1390139A (en) 2003-01-08
KR20020069512A (en) 2002-09-04
ZA200202822B (en) 2003-09-23
WO2001034137A2 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
NO20022245L (en) 2002-07-09
NZ517667A (en) 2004-05-28
BR0015490A (en) 2002-07-09
CA2391416A1 (en) 2001-05-17
WO2001034137A3 (en) 2002-02-14
HUP0204449A3 (en) 2006-02-28
TR200201245T2 (en) 2004-08-23
AR032432A1 (en) 2003-11-12
EA200200545A1 (en) 2002-12-26
AU778829B2 (en) 2004-12-23
CZ20021551A3 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
CY2016021I1 (en) VIRUS STRAIN FOR THE ONCOLYTIC THERAPY OF CANCER
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20025792L (en) Quinazoline derivatives for the treatment of tumors
NO20021474L (en) Compounds for the treatment of ischemia
NO20022245L (en) Oncolytic combinations for the treatment of cancer
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
NO20005864D0 (en) Quinasols for the treatment of brain tumor
FI20000863A (en) New treatment procedure
DK1176964T3 (en) Use of ET743 for the treatment of cancer
NO20020358D0 (en) Use of etodolac for the treatment of cancer
DE60023454D1 (en) LAGENMATERIALEN TENSID-MODIFIED CHELATBILDERN TREATED
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
NO20014725D0 (en) Enhanced cancer treatment with temozolomide
AU1916501A (en) Oncolytic combinations for the treatment of cancer
NO20013596D0 (en) Sludge treatment
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
NO20014228D0 (en) Radioactive cisplatin in the treatment of cancer
PT1043025E (en) TREATMENT OF CARCINOMA OF THE RENAL CELL
NO20014477L (en) Treatment of osteoarthritis
AU1592901A (en) Oncolytic combinations for the treatment of cancer
NO996166L (en) Procedures for the treatment of odluor
SE9903421D0 (en) treatment Procedure

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application